Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region
Abstract Background Weak governance over public sector pharmaceutical policy and practice limits access to essential medicines, inflates pharmaceutical prices, and wastes scarce health system resources. Pharmaceutical systems are technically complex and involve extensive interactions between the pri...
Main Authors: | Quinn Grundy, Lisa Parker, Anna Wong, Terence Fusire, Deirdre Dimancesco, Klara Tisocki, Helena Walkowiak, Taryn Vian, Jillian Kohler |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-03-01
|
Series: | Globalization and Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12992-022-00822-8 |
Similar Items
-
Medicine donations: a review of policies and practices
by: Hannah Permaul Flores, et al.
Published: (2023-09-01) -
Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance
by: Taryn Vian, et al.
Published: (2017-12-01) -
A Sociotechnical Approach to Analyze Pharmaceutical Policy and Services Management in Primary Health Care in a Brazilian Municipality
by: Noemia Liege Maria da Bernardo, et al.
Published: (2021-02-01) -
Government pharmaceutical pricing strategies in the Asia-Pacific region: an overview
by: Naina R. Verghese, et al.
Published: (2019-01-01) -
General characteristics of top 100 selling drugs: Turkish pharmaceutical market between 2003 and 2016
by: Guven Bektemur, et al.
Published: (2018-09-01)